An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer

被引:0
|
作者
Epperla N. [1 ]
George B. [1 ]
机构
[1] Department of Hematology and Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI
关键词
Positron Emission Tomography; Bevacizumab; Standardize Uptake Value; Lynch Syndrome; KRAS Mutation;
D O I
10.1007/s12029-015-9735-y
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:206 / 209
页数:3
相关论文
共 50 条
  • [41] MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers
    Choi, Yong Won
    Song, Young Soo
    Lee, Hyunwoo
    Yi, Kijong
    Kim, Young-Bae
    Suh, Kwang Wook
    Lee, Dakeun
    MEDICINE, 2016, 95 (15)
  • [42] BRAF and KRAS mutations in liver-resected metastatic colorectal cancer (mCRC) patients (pts)
    Bergamo, Francesca
    Schirripa, Marta
    Loupakis, Fotios
    Cremolini, Chiara
    Casagrande, Mariaelena
    Lonardi, Sara
    Aprile, Giuseppe
    Marmorino, Federica
    Salvatore, Lisa
    Antoniotti, Carlotta
    Sensi, Elisa
    Lupi, Cristiana
    De Maglio, Giovanna
    Bertorelle, Roberta
    Galiano, Antonella
    Griguolo, Gaia
    Balistreri, Mariangela
    Fontanini, Gabriella
    Zagonel, Vittorina
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [43] RE: Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer
    Hess, Lisa M.
    Carter, Gebra
    Smolen, Lee
    Bowman, Lee
    Chris, Philip von Hohnhorst
    Seagle, Chris
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02):
  • [44] BRAF Inhibitors in BRAF-Mutated Colorectal Cancer: A Systematic Review
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    Jumean, Samer
    Asfeen, Ummul
    Garcia, Jose
    Quirem, Murad
    Ahmad, Amaar
    Rayad, Mohammad Nabil
    Alkhlaifat, Osama
    Al Omour, Bader
    Chemarthi, Venkata S.
    Maroules, Michael
    Guron, Gunwant
    Shaaban, Hamid
    Suzuki, Hidekazu
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [45] KRAS, NRAS, and BRAF Mutation Pattern in Metastatic Colorectal Cancer: A Study from Northwest Iran
    Dolatkhah, Roya
    Dastgiri, Saeed
    Kermani, Iraj Asvadi
    Ziaei, Jamal Eivazi
    Nikanfar, Alireza
    Sanaat, Zohreh
    Sadat, Amir Taher Eftekhar
    Somi, Mohammad Hossein
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (08) : EC9 - EC13
  • [46] Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer
    Akhoundova, Dilara
    Pietge, Heike
    Hussung, Saskia
    Kiessling, Michael
    Britschgi, Christian
    Zoche, Martin
    Rechsteiner, Markus
    Weber, Achim
    Fritsch, Ralph M.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1082 - 1087
  • [47] Difference in appearance of KRAS mutated ctDNA in patients with metastatic colorectal cancer during treatments.
    Takayama, Yuji
    Suzuki, Koichi
    Ichida, Kosuke
    Fukui, Taro
    Watanabe, Fumiaki
    Kikugawa, Rina
    Hasegawa, Fumi
    Tsujinaka, Shingo
    Miyakura, Yasuyuki
    Noda, Hiroshi
    Konishi, Fumio
    Rikiyama, Toshiki
    CANCER SCIENCE, 2018, 109 : 458 - 458
  • [48] Phase Ib study of vemurafenib in combination with irinotecan and cetuximab in patients with BRAF-mutated metastatic colorectal cancer and advanced cancers.
    Hong, David S.
    Morris, Van Karlyle
    El Osta, Badi Edmond
    Fu, Siqing
    Overman, Michael J.
    Piha-Paul, Sarina Anne
    Subbiah, Vivek
    Kee, Bryan K.
    Tsimberidou, Apostolia Maria
    Zinner, Ralph
    Fogelman, David R.
    Bellido, Jorge
    Shureiqi, Imad
    Meric-Bernstam, Funda
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] Pilot study of vemurafenib and panitumumab combination therapy in patients with BRAF V600E mutated metastatic colorectal cancer.
    Yaeger, Rona D.
    Cercek, Andrea
    O'Reilly, Eileen Mary
    Reidy, Diane Lauren
    Kemeny, Nancy E.
    Wolinsky, Tamar
    Gollub, Marc J.
    Lacouture, Mario E.
    Rosen, Neal
    Vakiani, Efsevia
    Saltz, Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [50] BRAF K601E-mutated metastatic colorectal cancer in response to combination therapy with encorafenib, binimetinib, and cetuximab: A case report
    Sasaki, Makiko
    Shimura, Takaya
    Nishie, Hirotada
    Kuroyanagi, Keita
    Kanno, Takuya
    Fukusada, Shigeki
    Sugimura, Naomi
    Mizuno, Yusuke
    Nukui, Takayuki
    Uno, Konomu
    Kojima, Yuki
    Nishigaki, Ruriko
    Tanaka, Mamoru
    Ozeki, Keiji
    Kubota, Eiji
    Kataoka, Hiromi
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (07)